InvestmentJul 7, 2026, 05:32 PM
Vivos Therapeutics Raises $2.1M in PIPE Offering
AI Summary
Vivos Therapeutics, Inc. completed a Private Investment in Public Equity (PIPE) offering, raising approximately $2.1 million. The company sold 3,608,496 units, each comprising Series A Convertible Preferred Stock, Common Stock warrants, and transferable subscription rights, to V-Co Investors 4 LLC and Bigger Capital Fund, LP. A significant portion of the funding, $1 million, came from the conversion of a prior bridge promissory note. The net proceeds will be used for general working capital.
Key Highlights
- Completed a Private Investment in Public Equity (PIPE) offering.
- Raised approximately $2.1 million in gross proceeds.
- Sold 3,608,496 units at a purchase price of $0.582 per unit.
- Each unit included Series A Convertible Preferred Stock and Common Stock Warrants.
- $1 million of the proceeds converted from a prior bridge promissory note.
- CEO R. Kirk Huntsman indirectly participated in the offering.
- Net proceeds will be used for general working capital purposes.
- Warrants are exercisable at $0.456 per share for a five-year term.
Price Impact
More from VVOS